Miami Brain Symposium, Fourth Annual
The Miami Brain Symposium will focus on state-of-the-art approaches in the management of primary and metastatic central nervous systems tumors, along with an understanding of current standards of care and a look at future directions. This virtual symposium will engage participants as the expert faculty navigate through complex cases, novel treatment strategies and lively panel discussions.
Educational Objectives
Upon completion of this symposium, participants should be better able to:
- Examine the role of molecular histopathology in the diagnosis, characterization and management of primary and metastatic brain tumors.
- Explain the recent neurosurgical, radiation, immunotherapy and targeted medical therapy options for gliomas.
- Recognize the standard approaches and controversies in management strategies for brain metastases.
- Describe the results of observation, surgery, radiotherapy and radiosurgery for cavernous sinus meningiomas.
- Examine the current trends and future medical, neurosurgical and radiation therapy options for ependymoma.
Who Should Attend
Adult and pediatric neurologists, adult and pediatric medical oncologists, neurosurgeons, neuro-oncologists, medical oncologists, neuroradiologists, neuropsychologists, diagnostic radiologists, radiation oncologists, emergency medicine physicians, neuroscience nurses, neurosurgery nurses, nurse practitioners, physical therapists, respiratory therapists, dietitians, radiology technologists, clinical pharmacists, rehabilitation and pain management specialists and physician assistants, as well as other specialists interested in the fields of neuro-oncology and neuroscience.
In particular, this course will add tremendous value to residents in training as well as fellows in multiple specialties, including family practice, internal medicine, pediatrics, neurology, neurosurgery, medical oncology, radiation oncology, radiology and pathology.
Registration and Fees
This live virtual symposium is offered free of charge.
Event date: Friday, December 3, 2021